Skip Nav Destination
Issues
October 2017
ISSN 2296-5270
EISSN 2296-5262
In this Issue
Journal Name Change
Vol. 1-36 (1978-2013) were published under the journal's former title Onkologie.
Oncology Research and Treatment 2017, Vol. 40, No. 11
Editorial Board / Contents / Imprint
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 645–650.
https://doi.org/10.1159/000484306
Editorial
Immune Therapy of Lympho-Hemopoietic Malignancies
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 652–653.
https://doi.org/10.1159/000484052
Review Article
Checkpoint Inhibition in Hodgkin Lymphoma - a Review
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 654–660.
https://doi.org/10.1159/000481800
Checkpoint Inhibition in Non-Hodgkin's Lymphoma
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 662–672.
https://doi.org/10.1159/000481888
Cellular Immunotherapy in B-Cell Malignancy
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 674–681.
https://doi.org/10.1159/000481946
Wilms' Tumor Gene 1 (WT1) Peptide Vaccine Therapy for Hematological Malignancies: From CTL Epitope Identification to Recent Progress in Clinical Studies Including a Cure-Oriented Strategy
Subject Area:
Oncology
Yoshihiro Oka; Akihiro Tsuboi; Jun Nakata; Sumiyuki Nishida; Naoki Hosen; Atsushi Kumanogoh; Yusuke Oji; Haruo Sugiyama
Oncol Res Treat (2017) 40 (11): 682–690.
https://doi.org/10.1159/000481353
Specific Adoptive Cellular Immunotherapy in Allogeneic Stem Cell Transplantation
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 691–696.
https://doi.org/10.1159/000484051
Original Article
Definitive Radiotherapy for Primary Squamous Cell Carcinoma of the Vagina: Are High-Dose External Beam Radiotherapy and High-Dose-Rate Brachytherapy Boost the Best Treatment? Experience of Two Italian Institutes
Subject Area:
Oncology
Concetta Laliscia; Angiolo Gadducci; Maria G. Fabrini; Amelia Barcellini; Maria E. Guerrieri; Emanuela Parietti; Stefano Ursino; Riccardo Morganti; Ines Cafaro; Fabiola Paiar
Oncol Res Treat (2017) 40 (11): 697–701.
https://doi.org/10.1159/000480350
Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 702–706.
https://doi.org/10.1159/000479068
Circulating Cell-Free DNA Levels in Patients with Metastatic Renal Cell Carcinoma
Subject Area:
Oncology
Keren Rouvinov; Wilmosh Mermershtain; Hadas Dresler; Samuel Ariad; Reut Riff; Noa Shani-Shrem; Daniel Keizman; Amos Douvdevani
Oncol Res Treat (2017) 40 (11): 707–710.
https://doi.org/10.1159/000479523
Society Bulletins
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 711–717.
https://doi.org/10.1159/000484125
PharmaForum
Rezidivrisiko langfristig minimiert
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 719.
https://doi.org/10.1159/000484307
5 Jahre Erfahrung mit dem 5-Tages-Regime
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 721.
https://doi.org/10.1159/000484308
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 723.
https://doi.org/10.1159/000484309
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 724–725.
https://doi.org/10.1159/000484310
PharmaNews
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 726–727.
https://doi.org/10.1159/000484311
Meetings and Conferences
Subject Area:
Oncology
Oncol Res Treat (2017) 40 (11): 729–732.
https://doi.org/10.1159/000484124
